Therefore, we propose a robust framework based on a bootstrap strategy to discover a set of reproducible survival markers that best correlate with the IHC clinical factors ER, PR and HER2 (that are determined in routine clinical practice in breast cancer). Here, PGR is linked to breast cancer.